Some flavonoids, such as epigallocatechin-3-Gallate, serve as NRF2 agonists to activate NRF2-HO-1 and NRF2/ARE pathways, thus reversing the COVID-19 progression (41). The gene discussed is NFE2L2; the disease is COVID-19.